Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 May;47(5):1520-1540.
doi: 10.1002/hed.28109. Epub 2025 Feb 12.

Global Incidence, Mortality, and Risk Factors of Stroke in Multi-Modality Head and Neck Cancer Treatment-A Systematic Review and Meta-Analysis

Srivatsa Surya Vasudevan  1 , Elise Ericksen  2 , Victor Albornoz  1 , Elizabeth Bryan  2 , Lindsay Olinde  1 , Cherie-Ann O Nathan  1   3
Affiliations
Meta-Analysis

Global Incidence, Mortality, and Risk Factors of Stroke in Multi-Modality Head and Neck Cancer Treatment-A Systematic Review and Meta-Analysis

Srivatsa Surya Vasudevan et al. Head Neck. 2025 May.

Abstract

Background: Head and neck cancer (HNC) due to its nature and proximity to essential vasculature, along with different treatments, can lead to stroke, significantly contributing to morbidity and mortality. Our aim is to systematically evaluate the association of stroke incidence, mortality, and predictors with HNC treatment.

Methods: Pubmed, Web of Science, Embase, and ScienceDirect were searched from inception to July 2024 for articles reporting stroke incidences, mortality, or associated risk factors following treatment in HNC patients. A random-effects meta-analysis assessed cumulative incidence and mortality rates with proportional analysis and risk factors using hazard ratios (HRs) associated with HNC treatment. Subgroup analyses of incidence and mortality were conducted for pre- and post-2010 periods, reflecting changes in stroke protocols.

Results: Out of 1561 studies, 69 studies with 258 850 HNC patients were included. The global cumulative incidence of stroke in HNC was 4.1% (95% CI: 3.3%-5.0%), with similar rates before and after 2010 (4.4% vs. 4.0%). In patients undergoing chemoradiotherapy (CRT), stroke incidence was 4.9% (95% CI: 3.5%-6.7%) with a median time to first stroke of 45 months (range: 14-51.7 months). Following radiation therapy (RT), stroke incidence was 3.8% (95% CI: 2.7%-5.3%) with a median time to stroke of 36 months (range: 6.8-130 months). The incidence rates of stroke in HNC patients were higher compared to the general population (HR: 1.69, 95% CI: 1.24-2.31, p = 0.001). Stroke mortality decreased from 28.5% (95% CI: 11.6%-54.9%) pre-2010 to 14.5% (95% CI: 11.6%-17.9%) 2010-2024. Stroke mortality was 39.3% (95% CI: 17.8%-66.0%) post-CRT and 21% (95% CI: 7.2%-47.7%) post-RT. Hypertension (HR = 1.75), diabetes (HR = 1.71), and age > 65 (HR = 2.17) increased stroke risk (p < 0.0001 for all). Geographically, South Korea (6.6%) had the highest incidence of stroke.

Conclusion: This is the first systematic review to analyze the association between stroke and HNC treatment. Stroke mortality decreased from 28.5% to 14.5% (pre-2010 vs. 2010-2024), with the highest mortality in the CRT group (39.3%). Given that stroke occurs 36-45 months after CRT, a screening protocol within 3-4 years is crucial.

Keywords: head and neck cancer; hemorrhagic stroke; incidence; ischemic stroke; mortality.

PubMed Disclaimer

References

    1. 2024 Head & Neck Cancer Data and Resources, “Nevada Cancer Coalition,” accessed November 19, 2024, https://www.nevadacancercoalition.org/blog/2024‐head‐neck‐cancer‐data‐an....
    1. S. Kassirian, A. Dzioba, S. Hamel, et al., “Delay in Diagnosis of Patients With Head‐And‐Neck Cancer in Canada: Impact of Patient and Provider Delay,” Current Oncology 27, no. 5 (2020): e467–e477, https://doi.org/10.3747/co.27.6547.
    1. H. Y. Sroussi, J. B. Epstein, R. Bensadoun, et al., “Common Oral Complications of Head and Neck Cancer Radiation Therapy: Mucositis, Infections, Saliva Change, Fibrosis, Sensory Dysfunctions, Dental Caries, Periodontal Disease, and Osteoradionecrosis,” Cancer Medicine 6, no. 12 (2017): 2918–2931, https://doi.org/10.1002/cam4.1221.
    1. S. S. Vasudevan, H. Deeb, A. Katta, et al., “Efficacy and Safety of Proton Therapy Versus Intensity‐Modulated Radiation Therapy in the Treatment of Head and Neck Tumors: A Systematic Review and Meta‐Analysis,” Head & Neck 46, no. 10 (2024): 2616–2631, https://doi.org/10.1002/hed.27877.
    1. S. S. Vasudevan, S. B. H. Sayed, P. Kapartiwar, et al., “Radiotherapy vs Surgery for Survival and Locoregional Control of Head and Neck Extramedullary Plasmacytoma: A Systematic Review and Meta‐Analysis,” JAMA Otolaryngology. Head & Neck Surgery 150, no. 10 (2024): 887–895, https://doi.org/10.1001/jamaoto.2024.2597.

MeSH terms